Canada Hemofiltration Machine Market Size & Outlook, 2025-2033
Canada Hemofiltration Machine Market Insights
- Based on Reed Intelligence findings, the Canada Hemofiltration Machine Market reached USD 140.71 Million in 2024 and is estimated to attain USD 215.08 Million by 2033.
- From 2026 to 2033, the Canada market is expected to grow at a steady CAGR of 4.86%.
- Within the Application category, Acute Kidney Injury dominated in 2024 in terms of market size contribution.
- Over the forecast period, Chronic Kidney Disease is forecasted to deliver the fastest growth, positioning it as the most lucrative Application segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2024, Canada accounted for 8.04% of the global Hemofiltration Machine Market size.
- By 2033, United States is expected to lead the global Hemofiltration Machine Market in terms of market size.
- Within North America, United States is projected to dominate the regional Hemofiltration Machine Market size by 2033.
- United States is identified as the fastest-growing market in North America, anticipated to reach USD 680.63 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 140.71 Million |
| Market Size In 2033 | USD 215.08 Million |
| Largest segment | Acute Kidney Injury |
| Units | Revenue in USD Million |
| CAGR | 4.86% (2025-2033) |
| Segmnetation Covered | |
| Application |
|
| End Use |
|
| Product Type |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Hemofiltration Machine Market Application 2025-2033 (USD Million)
| Application | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Kidney Injury | XX.x | XX.x | XX.x | 68.51 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Chronic Kidney Disease | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Therapeutic Apheresis | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Hemofiltration Machine Market End Use 2025-2033 (USD Million)
| End Use | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 73.86 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Dialysis Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Home Care | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Hemofiltration Machine Market Product Type 2025-2033 (USD Million)
| Product Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Continuous Renal Replacement Therapy Machines | XX.x | XX.x | XX.x | 74.1 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Portable Hemofiltration Machines | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Single-Needle Dialysis Machines | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
